Best treatments for retinal vein occlusion
5 products may treat retinal vein occlusion, spanning FDA drug classes such as vascular endothelial growth factor inhibitor. The current highest-rated option is lucentis. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 5 drugs we list for retinal vein occlusion, none are yet flagged as generics in our price data, spanning classes such as vascular endothelial growth factor inhibitor. 3 of 5 carry a safety score, from 68 to 72 out of 100. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for retinal vein occlusion — so confirm the right choice with your prescriber.
Top-rated picks for retinal vein occlusion: 1. Lucentis · 2. Susvimo · 3. Cimerli
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Injectable | Vascular Endothelial Growth Factor Inhibitor | No data | — | View → | |
| 2 | 72/100 | Prescription | Injectable | Vascular Endothelial Growth Factor Inhibitor | No data | — | View → | |
| 3 | 68/100 | Prescription | Injectable | — | No data | — | View → | |
| 4 | Not yet rated | Prescription | Injectable | — | No data | — | View → | |
| 5 | Not yet rated | Prescription | Injectable | — | No data | — | View → |
Narrow by drug class
Explore the class hubs: vascular endothelial growth factor inhibitor
Full ranking · 5 treatments
lucentis
PrescriptionFDA-sourced
Lucentis (Ranibizumab) is a vascular endothelial growth factor inhibitor used to treat Diabetic Retinopathy, Macular Edema, Retinal Vein Occlusion.
Price varies
susvimo
Boxed warningPrescriptionFDA-sourced
Susvimo (Ranibizumab) is a vascular endothelial growth factor inhibitor used to treat Diabetic Retinopathy, Macular Edema, Retinal Vein Occlusion.
Price varies
cimerli
PrescriptionFDA-sourced
Cimerli (Ranibizumab-Eqrn) is a medication used to treat Diabetic Retinopathy, Macular Edema, Retinal Vein Occlusion.
Price varies
byooviz
PrescriptionFDA-sourced
Byooviz (Ranibizumab-Nuna) is a medication used to treat Diabetic Retinopathy, Macular Edema, Retinal Vein Occlusion.
Price varies
nufymco
PrescriptionFDA-sourced
Nufymco (Ranibizumab-Leyk) is a medication used to treat Diabetic Retinopathy, Macular Edema, Retinal Vein Occlusion.
Price varies
Frequently asked
- What treats retinal vein occlusion?
- Our catalog lists 5 products that may treat retinal vein occlusion, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is lucentis.
- What is the best-rated treatment for retinal vein occlusion?
- By our independent recall-safety rating — not an efficacy measure — lucentis ranks highest among the products we list for retinal vein occlusion. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat retinal vein occlusion?
- Treatments for retinal vein occlusion span FDA drug classes including vascular endothelial growth factor inhibitor. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.
Where this ranking comes from
Our score is computed from public FDA data — not from opinion, sponsorship or user votes. How we rate.
- FDA Drug Enforcement (recall) database — the recall history behind the safety score
- DailyMed (NIH National Library of Medicine) — the FDA labels we quote for uses, dosing and warnings
- Drugs@FDA — approvals, strengths and marketing status